Characterization of a novel CYP2A7/CYP2A6 hybrid allele (CYP2A6*12) that causes reduced CYP2A6 activity.
about
The ability of plasma cotinine to predict nicotine and carcinogen exposure is altered by differences in CYP2A6: the influence of genetics, race, and sexGenetic vulnerability and susceptibility to substance dependence.Rapid detection of the CYP2A6*12 hybrid allele by Pyrosequencing technology.Novel DNA sequence variations of cytochrome P450 genes in the Han Chinese population.The contribution of common CYP2A6 alleles to variation in nicotine metabolism among European-AmericansOrphans in the human cytochrome P450 superfamily: approaches to discovering functions and relevance in pharmacology.Genetically decreased CYP2A6 and the risk of tobacco dependence: a prospective study of novice smokers.A Genome-Wide Association Study of a Biomarker of Nicotine Metabolism.CYP2A6 and CYP2B6 genetic variation and its association with nicotine metabolism in South Western Alaska Native peopleCohort Profile: The Nicotine Dependence in Teens (NDIT) Study.Hepatic CYP2A6 levels and nicotine metabolism: impact of genetic, physiological, environmental, and epigenetic factors.CYP2A6 polymorphisms: is there a role for pharmacogenomics in preventing coumarin-induced hepatotoxicity in lymphedema patients?Characterization of orphan human cytochromes P450.Genetic variability in CYP2A6 and the pharmacokinetics of nicotine.CYP2A6 polymorphisms and risk for tobacco-related cancers.Distribution of polymorphic variants of CYP2A6 and their involvement in nicotine addiction.A nicotine C-oxidase gene (CYP2A6) polymorphism important for promoter activity.CYP2A6 genotyping methods and strategies using real-time and end point PCR platforms.Novel human CYP2A6 alleles confound gene deletion analysis.CYP2A6 genetic polymorphisms and correlation with smoking status in Brazilians.Differences between Spaniards and Ecuadorians in CYP2A6 allele frequencies: comparison with other populations.Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy.Variation in CYP2A6 Activity and Personalized Medicine.
P2860
Q24595571-C485CF0E-6FB0-4F54-BB91-1D417E3B9D21Q27686799-D1ED33C4-BE5B-4328-B7A5-064CCDA83A0BQ33496353-64D85B7A-225D-45A3-A782-E9D07B51939FQ34963630-E94DDDA1-643F-4775-9D93-1610C7EA468FQ35048184-4DF2513C-B7E5-4088-9E4E-FDBEB9F18DAEQ35122778-030C7A6E-D93E-465A-9D35-A81E5FEDCC6DQ35539136-FC707536-BD4F-402F-BC56-780F895BE6CFQ35788753-07359601-8BCD-4815-9E0F-5DF40BE4A2A8Q35949266-56083073-D60D-4D2E-B805-C62480281634Q36376677-85048AEE-D5AF-478E-A6A8-1E83B0684A25Q36459910-936A76D6-4364-4505-A20E-6B9D75E9EFC7Q36730627-AE2EA7DD-25D3-4F4A-8C0E-B68B2A35D6A5Q36929625-F4E6D200-BA39-4BA8-A34C-ABBDD5F0A50CQ36989832-16F394A7-AD71-4A7B-8DE2-2711A7B093BEQ37329175-EED4A715-8FC7-4240-B791-551DEA7734FFQ38683483-0C237A4B-2720-4C18-81B9-CE0A15D03320Q40587899-0FD97618-C7B8-4DE7-9864-60B733146A04Q41927477-D05F6D0C-F350-43E2-A741-AA200837AB25Q44957920-579DE0E8-E111-4888-8359-22EBED2530BAQ45144875-462FF4BB-15FC-4DCA-805D-7D404191701FQ46436451-803DADF6-5325-420D-8077-2238808429C5Q46886466-D8F2DB79-A103-407A-B39A-AC973E63B7E3Q47163198-00FCACAB-81E2-4EDC-9E91-2C2BCB5D0652
P2860
Characterization of a novel CYP2A7/CYP2A6 hybrid allele (CYP2A6*12) that causes reduced CYP2A6 activity.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Characterization of a novel CY ...... auses reduced CYP2A6 activity.
@en
type
label
Characterization of a novel CY ...... auses reduced CYP2A6 activity.
@en
prefLabel
Characterization of a novel CY ...... auses reduced CYP2A6 activity.
@en
P2093
P2860
P356
P1433
P1476
Characterization of a novel CY ...... auses reduced CYP2A6 activity.
@en
P2093
Arja Rautio
Blanca Sinues
MariCarmen Ledesma
Maria Luisa Bernal Ruiz
Mikael Oscarson
Roman A McLellan
Vendela Asp
P2860
P304
P356
10.1002/HUMU.10126
P577
2002-10-01T00:00:00Z